<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Charset + Viewport -->
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1, viewport-fit=cover" />

  <!-- Indexing & Privacy -->
  <meta name="robots" content="noindex, nofollow" />
  <meta name="referrer" content="strict-origin-when-cross-origin" />

  <!-- Theming & UX -->
  <meta name="color-scheme" content="light dark" />
  <meta name="theme-color" content="#003366" />
  <meta name="format-detection" content="telephone=no, address=no, email=no" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="default" />
  <meta name="mobile-web-app-capable" content="yes" />

  <!-- Title + Description -->
  <title>Clinical Summary – Carbamazepine Intolerance and Drug Sensitivity Pattern</title>
  <meta name="description" content="Concise clinical summary of carbamazepine intolerance, autonomic reaction, and historical sensitivity to neuro-active drugs, with ambulance assessment and ECG values." />

  <!-- Canonical -->
  

  <!-- Open Graph -->
  <meta property="og:title" content="Clinical Summary – Carbamazepine Intolerance and Drug Sensitivity Pattern" />
  <meta property="og:description" content="Concise clinical summary of carbamazepine intolerance, autonomic reaction, and historical sensitivity to neuro-active drugs, with ambulance assessment and ECG values." />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="" />
  <meta property="og:site_name" content="James Saint" />
  <meta property="og:locale" content="en_GB" />
  <meta property="og:image" content="https://jamessaint.github.io/images/seed-of-life-gold-default.png" />
  <meta property="og:image:width" content="1200" />
  <meta property="og:image:height" content="630" />

  <!-- Twitter Cards -->
  <meta name="twitter:card" content="summary_large_image" />
  <meta name="twitter:title" content="Clinical Summary – Carbamazepine Intolerance and Drug Sensitivity Pattern" />
  <meta name="twitter:description" content="Concise clinical summary of carbamazepine intolerance, autonomic reaction, and historical sensitivity to neuro-active drugs, with ambulance assessment and ECG values." />
  <meta name="twitter:image" content="https://jamessaint.github.io/images/seed-of-life-gold-default.png" />

  <!-- App Icons + Manifest -->
  <link rel="apple-touch-icon" sizes="180x180" href="https://jamessaint.github.io/images/icons/apple-touch-icon.png" />
  <link rel="icon" type="image/png" sizes="32x32" href="https://jamessaint.github.io/images/icons/favicon-32x32.png" />
  <link rel="icon" type="image/png" sizes="16x16" href="https://jamessaint.github.io/images/icons/favicon-16x16.png" />
  <link rel="manifest" href="https://jamessaint.github.io/site.webmanifest" />
  <link rel="mask-icon" href="https://jamessaint.github.io/images/icons/safari-pinned-tab.svg" color="#003366" />
  <meta name="msapplication-TileColor" content="#003366" />

  <!-- Preconnect/DNS Prefetch for performance -->
  <link rel="preconnect" href="https://cdn.jsdelivr.net" crossorigin>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link rel="dns-prefetch" href="//cdn.jsdelivr.net">
  <link rel="dns-prefetch" href="//fonts.googleapis.com">
  <link rel="dns-prefetch" href="//fonts.gstatic.com">

  <!-- CSS Framework + Fonts -->
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet" />
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;600;700&display=swap" rel="stylesheet">
  <link href="https://jamessaint.github.io/medical/global_styles.css" rel="stylesheet" />

  <!-- Mild Content Security Policy -->
  <meta http-equiv="Content-Security-Policy" content="
    default-src 'self';
    img-src 'self' https: data:;
    style-src 'self' 'unsafe-inline' https://fonts.googleapis.com https://cdn.jsdelivr.net;
    font-src 'self' https://fonts.gstatic.com data:;
    connect-src 'self';
    frame-ancestors 'none';
    base-uri 'self';
    form-action 'self'
  ">

  <!-- Structured Data -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "WebPage",
    "name": "Clinical Summary – Carbamazepine Intolerance and Drug Sensitivity Pattern",
    "url": "",
    "description": "Concise clinical summary of carbamazepine intolerance, autonomic reaction, and historical sensitivity to neuro-active drugs, with ambulance assessment and ECG values.",
    "inLanguage": "en-GB",
    "isPartOf": { "@type": "WebSite", "name": "James Saint", "url": "https://jamessaint.github.io/" }
  }
  </script>
</head>
<body>
  <main class="content container">
    <nav aria-label="breadcrumb">
      <ol class="breadcrumb">
        <li class="breadcrumb-item"><a href="/medical">Medical</a></li>
        <li class="breadcrumb-item"><a href="/medical/neurological">Neurological</a></li>
        <li class="breadcrumb-item active" aria-current="page">Clinical Summary</li>
      </ol>
    </nav>

    <header>
      <h1>Clinical Summary – Carbamazepine Intolerance</h1>
      <p class="meta">Prepared: 12 Oct 2025</p>
    </header>

    <section class="section card-like">
      <h2>Context</h2>
      <p>History of intolerance to duloxetine, gabapentin, pregabalin, and amitriptyline with autonomic and histaminic features. Carbamazepine 100 mg was trialled as a reluctant final conventional option under neurology guidance.</p>
    </section>

<section class="section card-like" id="recent-events">
  <h2>Recent Events</h2>
  <div class="table-wrap">
    <table>
      <tbody>
        <tr>
          <th>11 Oct 2025</th>
          <td>
            Autonomic episode after a warm bath at ~13:00, approximately 22 hours after 100 mg carbamazepine (15:00 on 10 Oct). Dizziness, near-syncope, pulse variability 111 → 85 → 110 bpm, chest and left arm tightness, facial tingling, occipital constriction, headache. Sat on the floor until stable. Considered calling 111/ambulance. <a href="Autonomic_Episode_After_Bath_2025-10-11.html">Full entry</a>.
          </td>
        </tr>
        <tr>
          <th>12 Oct 2025</th>
          <td>
            Generalised pruritus several hours after second 100 mg dose: scalp, underarms, chest, groin; heat–cold mismatch; sleep disrupted; no visible rash at time of logging. <a href="Medication_Log_Carbamazepine_2025-10-12.html">Full entry</a>.
          </td>
        </tr>
        <tr>
          <th>12 Oct 2025</th>
          <td>
            111 called. Ambulance attendance after ~2.5 hours. Took chlorphenamine 4mg, cooled outside, nicotine used, symptoms improved prior to arrival. Paramedics recorded stable vitals and normal ECG; discharged with advice to follow up GP/neurology.
          </td>
        </tr>
      </tbody>
    </table>
  </div>
</section>

    <section class="section card-like">
      <h2>ECG Parameters (Paramedic Printout)</h2>
      <table>
        <tr><th>Heart rate</th><td>100 bpm</td></tr>
        <tr><th>PR interval</th><td>126 ms</td></tr>
        <tr><th>QRS duration</th><td>91 ms</td></tr>
        <tr><th>QT interval</th><td>328 ms</td></tr>
        <tr><th>QTc</th><td>425 ms</td></tr>
        <tr><th>P axis</th><td>80°</td></tr>
        <tr><th>QRS axis</th><td>73°</td></tr>
        <tr><th>T axis</th><td>95°</td></tr>
      </table>
      <p class="meta">Interpretation: within normal limits for rate-adjusted intervals and axes. No acute electrical abnormality identified.</p>
    </section>

    <section class="section card-like">
      <h2>Clinical Interpretation</h2>
      <p>Pattern is consistent with autonomic and mast-cell activation in response to neuro-active agents, now including carbamazepine. This mirrors prior reactions to duloxetine and tricyclics where antihistamines were advised with only marginal help. The reactions are physiological and reproducible across classes.</p>
    </section>

    <section class="section card-like">
      <h2>Requests to Care Team</h2>
      <ul>
        <li>Record carbamazepine as <strong>intolerant / adverse reaction</strong>.</li>
        <li>Consider <strong>mast-cell workup</strong> (baseline and event tryptase, plasma/urine histamine, DAO).</li>
        <li>Consider <strong>pharmacogenomic profiling</strong> for CYP2D6/CYP3A4 and related pathways before new prescriptions.</li>
        <li>Discuss <strong>Nabiximols (THC/CBD oromucosal spray)</strong> as preferred therapeutic route given intolerance to sodium-channel and serotonergic agents.</li>
        <li>Provide guidance on safe discontinuation and washout period following last dose.</li>
      </ul>
    </section>

    <section class="section card-like">
      <h2>Patient Statement</h2>
      <p>I have been reluctant with duloxetine, pregabalin, gabapentin, and amitriptyline due to prior experiences. Carbamazepine has produced similar adverse patterns without pain relief. I wish to stop it now and focus on a treatment pathway that does not trigger autonomic or mast-cell reactions. I request support in accessing Nabiximols through NHS pathways or exceptional-case review.</p>
    </section>
  <!-- Footer -->
<footer class="site-footer mt-4" role="contentinfo" aria-label="Site footer">
  <div class="footer-container text-center">
    <hr class="footer-rule" />
    <div class="footer-note mb-1">
      Private & Confidential · Intended for the named clinical team and the patient only.
    </div>
    <div class="footer-copy">
      © <span id="copy-year"></span> James Saint. All rights reserved.
    </div>
  </div>
</footer>
<!-- Year Autoupdate -->
<script>
  (function () {
    var y = new Date().getFullYear();
    var el = document.getElementById('copy-year');
    if (el) el.textContent = y;
  })();
</script>

    </main>
</body>
</html>
